Cargando…

In Search of Targeted Therapies for Childhood Cancer

Detalles Bibliográficos
Autor principal:	Mackall, Crystal L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2011
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356018/ https://www.ncbi.nlm.nih.gov/pubmed/22655233 http://dx.doi.org/10.3389/fonc.2011.00018

Ejemplares similares

Immunotherapy Targets in Pediatric Cancer
por: Orentas, Rimas J., et al.
Publicado: (2012)

Identification of Cell Surface Proteins as Potential Immunotherapy Targets in 12 Pediatric Cancers
por: Orentas, Rimas J., et al.
Publicado: (2012)

Bioinformatic Description of Immunotherapy Targets for Pediatric T-Cell Leukemia and the Impact of Normal Gene Sets Used for Comparison
por: Orentas, Rimas J., et al.
Publicado: (2014)

Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers
por: Rossig, Claudia, et al.
Publicado: (2018)

The immunotherapy advancement targeting malignant blastomas in early childhood
por: Zang, Bolun, et al.
Publicado: (2023)

Targeting Sphingolipids for Cancer Therapy
por: Companioni, Osmel, et al.
Publicado: (2021)

Effects of RANKL-Targeted Therapy in Immunity and Cancer
por: Cheng, Michael L., et al.
Publicado: (2014)

From Therapy Resistance to Targeted Therapies in Prostate Cancer
por: Moreira-Silva, Filipa, et al.
Publicado: (2022)

Targeted Therapy for Breast Cancer Prevention
por: den Hollander, Petra, et al.
Publicado: (2013)

Editorial: Nanomedicine in Cancer Targeting and Therapy
por: Longo, João Paulo Figueiró, et al.
Publicado: (2021)

Mechanism of inflammasomes in cancer and targeted therapies
por: Gu, Qingdan, et al.
Publicado: (2023)

Chondroitin sulfate proteoglycan 4 specific chimeric antigen receptor therapy for pediatric solid tumors
por: Tschernia, Nicholas, et al.
Publicado: (2014)

Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces
por: Gallardo-Pérez, Moisés M., et al.
Publicado: (2023)

Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy
por: Guo, Rui, et al.
Publicado: (2022)

Targeting aldehyde dehydrogenase for prostate cancer therapies
por: Ma, Miao, et al.
Publicado: (2022)

PSMA-targeted therapy for non-prostate cancers
por: Wang, Jarey H., et al.
Publicado: (2023)

Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers
por: Espinosa, Maria L., et al.
Publicado: (2021)

Cardiac Surveillance for Early Detection of Late Subclinical Cardiac Dysfunction in Childhood Cancer Survivors After Anthracycline Therapy
por: Sofia, Rosaria, et al.
Publicado: (2021)

Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy
por: Kaur, Jasmeet, et al.
Publicado: (2021)

Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer
por: Xu, Donghan, et al.
Publicado: (2023)

The Evolution of Prostate Cancer Therapy: Targeting the Androgen Receptor
por: Aragon-Ching, Jeanny B.
Publicado: (2014)

Improvement of Cancer Immunotherapy by Combining Molecular Targeted Therapy
por: Kawakami, Yutaka, et al.
Publicado: (2013)

Targeting Oncogenic Mutant p53 for Cancer Therapy
por: Parrales, Alejandro, et al.
Publicado: (2015)

Targeted Therapy for Medullary Thyroid Cancer: A Review
por: Priya, S. R., et al.
Publicado: (2017)

Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017)

Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
por: Ming, Jie, et al.
Publicado: (2020)

Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges
por: Yu, De-Hua, et al.
Publicado: (2020)

Mutant p53 in Cancer Progression and Targeted Therapies
por: Zhu, Gaoyang, et al.
Publicado: (2020)

Targeted Therapies and Biomarkers in Small Cell Lung Cancer
por: Taniguchi, Hirokazu, et al.
Publicado: (2020)

The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
por: Guerra, Borja, et al.
Publicado: (2021)

Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
por: Li, Yue, et al.
Publicado: (2021)

In Vivo Targeting Replication Protein A for Cancer Therapy
por: VanderVere-Carozza, Pamela S., et al.
Publicado: (2022)

Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer
por: Wang, Hong-Tao, et al.
Publicado: (2022)

The Role of Feedback Loops in Targeted Therapy for Pancreatic Cancer
por: Gu, Weigang, et al.
Publicado: (2022)

Editorial: Advances in molecular targeted therapies of urologic cancers
por: Nitzsche, Bianca, et al.
Publicado: (2022)

Targeting immune-onco-metabolism for precision cancer therapy
por: Pajai, Sakshi, et al.
Publicado: (2023)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Targeted splicing therapy: new strategies for colorectal cancer
por: Zheng, Yifeng, et al.
Publicado: (2023)

Can intensity of long-term follow-up for survivors of childhood and teenage cancer be determined by therapy-based risk stratification?
por: Edgar, A B, et al.
Publicado: (2013)

Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia
por: Zhou, Ruizhi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hj71qsgmoml3a9af9g0qq2lv5v